Protease-activated receptor-2 (PAR-2): Structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes

被引:48
|
作者
Maryanoff, BE [1 ]
Santulli, RJ [1 ]
McComsey, DF [1 ]
Hoekstra, WJ [1 ]
Hoey, K [1 ]
Smith, CE [1 ]
Addo, M [1 ]
Darrow, AL [1 ]
Andrade-Gordon, P [1 ]
机构
[1] RW Johnson Pharmaceut Res Inst, Drug Discovery, Spring House, PA 19477 USA
关键词
protease-activated receptor; agonist peptides; intracellular calcium; structure-activity; tethered-ligand receptor; transfected cells;
D O I
10.1006/abbi.2000.2207
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protease-activated receptor-a (PAR-S) is a tethered-ligand, G-protein-coupled receptor that is activated by proteolytic cleavage or by small peptides derived from its cleaved N-terminal sequence, such as SLIGRL-NH2. To assess specific PAR activity, we developed an immortalized murine PAR-1 (-/-) cell line transfected with either human PAR-8 or PAR-1. A "directed" library of more than 100 PAR agonist peptide analogues was synthesized and evaluated for PAR-8 and PAR-1 activity to establish an in-depth structure-function profile for specific action on PAR-S. The most potent agonist peptides (EC50 = 2-4 muM) had Lys at position 6, Ala at position 4, and pFPhe at position 2; however, these also exhibited potent PAR-1 activity (EC50 = 0.05-0.35 muM). We identified SLIARK-NH2 and SL-Cha-ARL-NH2 as relatively potent, highly selective PAR-2 agonists with EC50 values of 4 muM. Position 1 did not tolerate basic, acidic, or large hydrophobic amino acids. N-Terminal capping by acetyl eliminated PAR-2 activity, although removal of the amino group reduced potency by just 4-fold. At position 2, substitution of Leu by Cha or Phe gave equivalent PAR-2 potency, but this modification also activated PAR-1, whereas Ala, Asp, Lys, or Gln abolished PAR-2 activity; at position 3, Re and Cha were optimal, although various amino acids were tolerated; at position 4, Ala or Cha increased PAR-2 potency 2-fold, although Cha introduced PAR-1 activity; at position 5, Arg or Lys could be replaced successfully by large hydrophobic amino acids. These results with hexapeptide C-terminal amides that mimic the native PAR-2 ligand indicate structural modes for obtaining optimal PAR-2 activity, which could be useful for the design of PAR-2 antagonists. (C) 2001 Academic Press.
引用
收藏
页码:195 / 204
页数:10
相关论文
共 50 条
  • [41] Activation of protease-activated receptor-2 (PAR-2) elicits nitric oxide-dependent dilatation of the basilar artery in vivo - Comment
    Katusic, ZS
    STROKE, 1998, 29 (07) : 1444 - 1444
  • [42] Activation of protease-activated receptor-2 disrupts vaginal epithelial barrier function
    Li, Yan
    Feng, Chong
    Wei, Xing
    Zhang, Jiyuan
    Zan, Ronghua
    Zheng, Guizhi
    Yang, Xiaoying
    Zhai, Jianjun
    CELL BIOLOGY INTERNATIONAL, 2014, 38 (11) : 1247 - 1251
  • [43] Expression of protease-activated receptor-2 (PAR-2) is related to advanced clinical stage and adverse prognosis in ovarian clear cell carcinoma
    Amen, Murasaki
    Ohishi, Yoshihiro
    Imamura, Hiroko
    Shinozaki, Tomoko
    Yasutake, Nobuko
    Kato, Kiyoko
    Oda, Yoshinao
    HUMAN PATHOLOGY, 2017, 64 : 156 - 163
  • [44] PROTEASE ACTIVATED RECEPTOR-2 (PAR-2) AND ACTIVATED PROTEIN C (APC) IN CARTILAGE DEGRADATION
    Jackson, M. T.
    Smith, M. M.
    Smith, S.
    Jackson, C.
    Little, C. B.
    OSTEOARTHRITIS AND CARTILAGE, 2010, 18 : S90 - S90
  • [45] Protease-activated receptor-2 turnover can be stimulated independently of receptor activation
    Hamilton, JR
    Chow, JM
    Cocks, TM
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R260 - R260
  • [46] Mechanisms for modulation of mouse gastrointestinal motility caused by protease-activated receptor (PAR)-1 and PAR-2 activation
    Sekiguchi, F
    Hasegawa, N
    Yonezawa, D
    Inoi, N
    Kanke, T
    Saito, N
    Kawabata, A
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 257P - 257P
  • [47] Protease activated receptor-2 (par-2) contribute to leukocyte adhesion and neointima formation
    Tennant, G.
    Wadsworth, R. M.
    Kennedy, S.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2006, 40 (06) : 904 - 905
  • [48] Differentiation of the vascular response to activation of thrombin receptor (TR) and protease activated receptor-2 (PAR-2) in anesthetized mice.
    Cheung, WL
    AndradeGordon, P
    Derian, CK
    Damiano, BP
    CIRCULATION, 1996, 94 (08) : 3441 - 3441
  • [49] Protease-activated receptor-2 (PAR-2) is a weak enhancer of mucin secretion by human bronchial epithelial cells in vitro
    Lin, Ko-Wei
    Park, Joungjoa
    Crews, Anne L.
    Li, Yuehua
    Adler, Kenneth B.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2008, 40 (6-7): : 1379 - 1388
  • [50] Protease-activated receptor 2 (PAR-2) biased agonism in ovarian cancer progression
    Pawar, Nisha R.
    Duru, Nadire
    Conway, Gregory D.
    Antalis, Toni M.
    FASEB JOURNAL, 2019, 33